Menu
Etoricoxib Tablet
Main view Additional view 1 Additional view 2 Additional view 3
NSAIDs (Anti-inflammatory) Tablet

Etoricoxib Tablet

120 mg

Active Ingredient
Etoricoxib
Estimated Price
Not specified

COX-2 selective NSAID. Lower GI risk. Caution in hypertension/cardiac history. Max 8 days for acute pain.

Consult Dr. Hutaif
Medical Disclaimer The information provided in this comprehensive guide is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with your physician before taking any new medication.

Etoricoxib Tablet: An Expert Medical SEO Guide for Orthopedic Pain and Inflammation Management

1. Comprehensive Introduction & Overview

Etoricoxib is a highly selective cyclooxygenase-2 (COX-2) inhibitor, a class of non-steroidal anti-inflammatory drugs (NSAIDs) distinguished by its targeted action. Developed to provide effective relief from pain and inflammation, Etoricoxib is a cornerstone medication in the management of various musculoskeletal and inflammatory conditions, particularly those encountered in orthopedic practice. Unlike non-selective NSAIDs that inhibit both COX-1 and COX-2 enzymes, Etoricoxib primarily targets COX-2, aiming to reduce the gastrointestinal side effects often associated with traditional NSAIDs while maintaining potent anti-inflammatory and analgesic properties.

This comprehensive guide, crafted by an expert Medical SEO Copywriter and Orthopedic Specialist, delves into the intricate details of Etoricoxib. We will explore its mechanism of action, pharmacokinetic profile, detailed clinical indications, precise dosage guidelines, critical contraindications, potential drug interactions, warnings for special populations like pregnant or lactating individuals, and essential overdose management strategies. Our goal is to provide a definitive resource for healthcare professionals, patients, and caregivers seeking authoritative information on Etoricoxib tablets.

2. Deep-dive into Technical Specifications & Mechanisms

2.1. Mechanism of Action: The Selective COX-2 Inhibition

Etoricoxib exerts its therapeutic effects by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme. To understand its action, it's crucial to differentiate between the two primary isoforms of the COX enzyme:

  • Cyclooxygenase-1 (COX-1): This is a constitutively expressed enzyme found in most tissues. It plays a vital role in maintaining physiological functions such such as gastric mucosal protection (by producing protective prostaglandins), renal blood flow regulation, and platelet aggregation (by producing thromboxane A2).
  • Cyclooxygenase-2 (COX-2): This isoform is generally inducible, meaning its expression is significantly upregulated in response to inflammatory stimuli, cytokines, and growth factors. COX-2 is primarily responsible for the synthesis of pro-inflammatory prostaglandins at sites of inflammation, pain, and fever.

Etoricoxib's high selectivity for COX-2 means it primarily blocks the production of these inflammatory prostaglandins, thereby reducing inflammation, pain, and fever. By largely sparing COX-1, Etoricoxib aims to mitigate the common gastrointestinal side effects (such as ulcers, bleeding, and dyspepsia) seen with non-selective NSAIDs, which inhibit both COX-1 and COX-2. This selective inhibition is particularly beneficial for patients requiring long-term anti-inflammatory therapy, offering a potentially improved gastrointestinal safety profile.

2.2. Pharmacokinetics: Absorption, Distribution, Metabolism, and Excretion

Understanding the pharmacokinetics of Etoricoxib is essential for optimizing its clinical use and managing potential drug interactions.

| Parameter | Description

Share this guide: